China Health Industries Holdings, Inc. Share Price Other OTC
Equities
CHHE
US1693981045
Pharmaceuticals
Sales 2022 | 267 22.27T | Sales 2023 | 1L 93.05L | Capitalization | 1.47Cr 122.26Cr |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | -1,39,809 x |
Net cash position 2022 | 3.8Cr 317.14Cr | Net Debt 2023 | 51.07L 43Cr | EV / Sales 2023 | 177 x |
P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
-35.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.71% |
Managers | Title | Age | Since |
---|---|---|---|
Xin Sun
CEO | Chief Executive Officer | 58 | - |
Melody Zhang
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Sun
CEO | Chief Executive Officer | 58 | - |
1st Jan change | Capi. | |
---|---|---|
+31.37% | 59TCr | |
-2.83% | 36TCr | |
+20.34% | 33TCr | |
+5.46% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+11.03% | 17TCr | |
-0.09% | 16TCr |